Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Subcutaneous Immunoglobulin (SCIG) injection bulk supplier for pharma manufacturers

Subcutaneous Immunoglobulin (Scig) Injection 20%, 10 mL/ampoule Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 20%, 10 mL/ampoule

Reference Brands: Hizentra, Cuvitru, Vivaglobulin(US)

Category: Plasma Products

SCIG provides pooled IgG antibodies directly into the tissue, boosting immune defense. It neutralizes pathogens, modulates immune responses, and reduces autoimmune activity. Benefits include convenient home administration, sustained antibody levels, fewer systemic side effects, improved quality of life, and consistent immune support in patients with immunodeficiency or autoimmune conditions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Subcutaneous Immunoglobulin (SCIG), marketed as Hizentra, Cuvitru, and Vivaglobulin, is approved in the US by the FDA and in the EU via EMA for primary immunodeficiency and autoimmune diseases. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, FDA review involves detailed assessment of clinical trials and manufacturing standards, while the EMA ensures compliance with regional quality and safety requirements. For expert guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring compliance is crucial for the safe, effective, and timely approval of SCIG products worldwide, supporting better patient outcomes.

Subcutaneous Immunoglobulin (Scig) Injection — third party manufacturing & bulk supply

Subcutaneous Immunoglobulin (Scig) Injection 20%, 10 mL/ampoule is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Subcutaneous Immunoglobulin (Scig) Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Subcutaneous Immunoglobulin (Scig) Injec... →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Subcutaneous Immunoglobulin (SCIG) is used to treat patients with primary immunodeficiency disorders and certain immune system deficiencies. It helps strengthen the immune system by providing antibodies that protect the body from infections.

Subcutaneous Immunoglobulin is made from purified human immunoglobulin G (IgG) antibodies obtained from pooled plasma collected from healthy donors.

Common trade names include Hizentra, Cuvitru, HyQvia, Gammanorm, Cutaquig, Xembify, and Subgam.

Several pharmaceutical companies manufacture SCIG products worldwide including CSL Behring, Takeda Pharmaceutical Company, and Grifols.

The generic name is Human Normal Immunoglobulin.

Common brand names include Hizentra, Cuvitru, HyQvia, Gammanorm, Cutaquig, Xembify, and Subgam.

Subcutaneous Immunoglobulin products are manufactured in several countries including the United States, Germany, Austria, and other regions by different plasma-derived pharmaceutical manufacturers.

Related Products

Marstacimab‑Hncq

Strength:
150 mg/mL

Form: injection (prefilled syringe)

Reference Brands: Hympavzi (USA)

View Details
Emicizumab‑Kxwh

Strength:
30 mg/mL, 60 mg/0.4 mL, 105 mg/0.7 mL

Form: Injection

Reference Brands: Hemlibra (USA/EU)

View Details
Concizumab-Mtci

Strength:
60 mg/1.5 mL, 150 mg/1.5 mL, 300 mg/3 mL

Form: Prefilled autoinjector

Reference Brands: Alhemo (USA/EU)

View Details
Fresh Frozen Plasma (Ffp) Powder For Reconstitution Or Liquid

Strength:
available in 200-250 mL units

Form: liquid units or lyophilized (freeze-dried) powder

Reference Brands: No specific brands

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.